DRUG-INDUCED OSTEONECROSES OF THE JAWS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper gives an update on jaw osteonecroses occurring with the use of different drugs and considers some diagnostic issues, treatment options, prognosis, and recommendations for the prevention of this disease.

Full Text

Restricted Access

About the authors

E. Basin

I.M. Sechenov First Moscow State Medical University

Email: kroko-stomatolog@mail.ru
Candidate of Medical Sciences

Yu. Medvedev

I.M. Sechenov First Moscow State Medical University

Email: kroko-stomatolog@mail.ru
Professor , MD

K. Polyakov

I.M. Sechenov First Moscow State Medical University

Email: kroko-stomatolog@mail.ru
Candidate of Medical Sciences

References

  1. Vahtsevanos K., Kyrgidis A., Verrou E. et al: Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw // J. Clin. Oncol. - 2009; 27: 5356-62.
  2. Saad F., Brown J., Van Poznak C. et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases // Ann. Oncol. - 2012; 23: 1341-7.
  3. Fehm T., Beck V., Banys M. et al. Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies // Gynecol. Oncol. - 2009; 112: 605-9.
  4. Yamazaki T., Yamori M., Ishizaki T. et al. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study // Int. J. Oral Maxillofac. Surg. - 2012; 41: 1397.
  5. Kyrgidis A., Vahtsevanos K., Koloutsos G. et al. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients // J. Clin. Oncol. - 2008; 26: 4634-8.
  6. Tsao C., Darby I., Ebeling P. et al. Oral health risk factors for bisphosphonateassociated jaw osteonecrosis // J. Oral Maxillofac. Surg. - 2013; 71: 1360-6.
  7. Dimopoulos M., Kastritis E., Bamia C. et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid // Ann. Oncol. - 2009; 20: 117-20.
  8. Ripamonti C., Maniezzo M., Campa T. et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan // Ann. Oncol. - 2009; 20: 137-45.
  9. Mehrotra B., Fantasia J., Ruggiero S. Outcomes of bisphosphonate related osteonecrosis of the jaw. Importance of staging and management. A large single institution update // J. Clin. Oncol. - 2008; 26: 20526.
  10. Carlson E., Basile J. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws // J. Oral Maxillofac. Surg. -2009; 67: 85-95.
  11. Graziani F., Vescovi P., Campisi G. et al. Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate related osteonecrosis of the jaws: a retrospective survey of 347 cases // J. Oral Maxillofac. Surg. - 2012; 70: 2501.
  12. Stanton D., Balasanian E. Outcome of surgical management of bisphosphonaterelated osteonecrosis of the jaws: review of 33 surgical cases // J. Oral Maxillofac. Surg. - 2009; 67: 943.
  13. Stockmann P., Vairaktaris E., Wehrhan F. et al. Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up // Support Care Cancer. -2010; 18: 449-60.
  14. Mucke T., Koschinski J., Deppe H. et al. Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws // J. Cancer Res. Clin. Oncol. - 2011; 137: 907.
  15. Eckardt A., Lemound J., Lindhorst D. et al. Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem // Anticancer Res. - 2011; 31: 2313-8.
  16. Ferlito S., Puzzo S., Palermo F. et al. Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases // Br. J. Oral Maxillofac. Surg. - 2012; 50: 425.
  17. Saussez S., Javadian R., Hupin C. et al. Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series // Laryngoscope. - 2009; 119: 323-9.
  18. Scoletta M., Arduino P., Dalmasso P. et al. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study // Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. - 2010; 110: 46-53.
  19. Van den Wyngaert T., Claeys T., Huizing M. et al. Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome // Ann. Oncol. - 2009; 20: 331-6.
  20. Wutzl A., Biedermann E., Wanschitz F. et al. Treatment results of bisphosphonaterelated osteonecrosis of the jaws // Head Neck. - 2008; 30: 1224-30.
  21. Vudiniabola S., Pirone C., Williamson J. et al. Hyperbaric oxygen in the therapeutic management of osteoradionecrosis of the facial bones // Int. J. Oral Maxillofac. Surg. - 2000; 29: 435-8.
  22. Fleisher K., Welch G., Kottal S. et al. Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers // Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. - 2010; 110: 509.
  23. Engroff S., Kim D. Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction? // J. Oral Maxillofac. Surg. - 2007; 65: 2374-85.
  24. Ferrari S., Bianchi B., Savi A. et al. Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis // J. Oral Maxillofac. Surg. - 2008; 66: 999-1003.
  25. Seth R., Futran N., Alam D. et al. Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws // Laryngoscope. - 2010; 120: 2165-71.
  26. Разуддинов С. Организация профилактического полоскания полости рта рабочих фосфорного производства // Вопр. стоматол. - 1984; 4: 96-8.
  27. Ергешбаев К.Е., Хамзаев Б.Д. Некоторые показатели неспецифической резистентности у рабочих фосфорного производства // Здравоохранение Казахстана. - 1981; 3: 47-9.
  28. Migliorati C., Casiglia J., Epstein J. et al. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper // J. Am. Dent. Assoc. - 2005; 136: 1658-68.
  29. Woo S., Hellstein J., Kalmar J. Systematic review: Bisphosphonates and osteonecrosis of the jaws // Ann. Intern. Med. - 2006; 144: 753-61.
  30. Lowe I. Профессиональные болезни. 1925; Вып. 2.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies